Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter

Neuropsychopharmacology

Volumn 38, Issue 12, 2013, Pages 2385-2392

  Calipari, Erin S ^a   Ferris, Mark J ^a   Zimmer, Benjamin A ^a   Roberts, David Cs ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cocaine; dopamine; dopamine transporter; nucleus accumbens; self administration; voltammetry

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG EFFECT; DRUG TOLERANCE; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SENSITIZATION; TISSUE SLICE;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG TOLERANCE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SYNAPSES; TIME FACTORS;

EID: 84888386583     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.136     Document Type: Article

References (51)

1. Addy NA, Daberkow DP, Ford JN, Garris PA, Wightman RM (2010). Sensitization of rapid dopamine signaling in the nucleus accumbens core and shell after repeated cocaine in rats. J Neurophysiol 104: 922-931.
2. Ahmed SH, Lenoir M, Guillem K (2013). Neurobiology of addiction vs drug use driven by lack of choice. Curr Opin Neurobiol 23: 1-7.
3. Ahmed SH, Lin D, Koob GF, Parsons LH (2003). Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem 86: 102-113. (Pubitemid 36753851)
4. Aragona BJ, Day JJ, Roitman MF, Cleaveland NA, Wightman RM, Carelli RM (2009). Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci 30: 1889-1899.
5. Blum K, Chen AL, Giordano J, Borsten J, Chen TJ, Hauser M et al (2012). The addictive brain: all roads lead to dopamine. J Psychoactive Drugs 44: 134-143.
6. Calipari ES, Ferris MJ, Melchior JR, Bermejo K, Salahpour A, Roberts DC et al (2012). Methylphenidate and cocaine selfadministration produce distinct dopamine terminal alterations. Addict Biol (in press).
7. Chen R, Daining CP, Sun H, Fraser R, Stokes SL, Leitges M et al (2013). Protein kinase Cb is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter. J Neurochem 125: 663-672.
8. Chen R, Furman CA, Zhang MJ, Kim MN, Gereau RW, Leitges M et al (2009). Protein kinase C beta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J Pharmacol Exp Therap 328: 912-920.
9. Dackis CA, O'Brien CP (2001). Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 21: 111-117. (Pubitemid 33109059)
10. Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DC, Jones SR (2012). Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology 37: 1708-1716.
11. Ferris MJ, Mateo Y, Roberts DC, Jones SR (2011). Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry 69: 201-207.
12. Filip M, Alenina N, Bader M, Przegaliński E (2010). Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol 15: 227-249.
13. Filip M, Frankowska M, Go"da A, Zaniewska M, Vetulani J, Przegaliński E (2006). Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. Eur J Pharmacol 541: 163-170.
14. Foster JD, Adkins SD, Lever JR, Vaughan RA (2008). Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 105: 1683-1699. (Pubitemid 351678491)
15. Hastrup H, Sen N, Javitch JA (2003). The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J Biol Chem 278: 45045-45048. (Pubitemid 37432635)
16. Hooks MS, Duffy P, Striplin C, Kalivas PW (1994). Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl) 115: 265-272. (Pubitemid 24207792)
17. Hurd YL, Weiss F, Koob GF, And NE, Ungerstedt U (1989). Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens-an in vivo Microdialysis Study. Brain Res 498: 199-203. (Pubitemid 19228184)
18. Izenwasser S (2004). The role of the dopamine transporter in cocaine abuse. Neurotox Res 6: 379-383 (review).
19. Jones SR, Lee TH, Wightman RM, Ellinwood EH (1996). Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) 126: 331-338. (Pubitemid 26276704)
20. Kalivas PW, Duffy P (1990). Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58. (Pubitemid 20110621)
21. Kalivas PW, Duffy P (1993). Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13: 266-275. (Pubitemid 23028742)
22. Kalivas PW, McFarland K (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44-56. (Pubitemid 36851162)
23. Koob GF (1996). Hedonic valence, dopamine and motivation. Mol Psychiatry 1: 186-189. (Pubitemid 126441291)
24. Koob GF, Le Moal M (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58. (Pubitemid 27446270)
25. Kristensen AS, Andersen J, J-rgensen TN, S-rensen L, Eriksen J, Loland CJ et al (2011). SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63: 585-640 (review).
26. Lack CM, Jones SR, Roberts DC (2008). Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats. Psychopharmacology (Berl) 195: 517-525. (Pubitemid 350161771)
27. Leyton M, Vezina P (2013). Striatal ups and downs: their roles in vulnerability to addictions in humans. Neurosci Biobehav Rev S0149-7634: 00019-5.
28. Liu Y, Morgan D, Roberts DCS (2007). Cross-sensitization of the reinforcing effects of cocaine and amphetamine in rats. Psychopharmacology (Berl) 195: 369-375. (Pubitemid 350160273)
29. Macey DJ, Rice WN, Freedland CS, Whitlow CT, Porrino LJ (2004). Patterns of functional activity associated with cocaine selfadministration in the rat change over time. Psychopharmacology (Berl) 172: 384-392. (Pubitemid 38650973)
30. Martin BJ, Naughton BJ, Thirtamara-Rajamani K, Yoon DJ, Han DD, Devries AC et al (2011). Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens. Synapse 65: 490-496.
31. Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30: 1455-1463. (Pubitemid 41153117)
32. Meil WM, Roll JM, Grimm JW, Lynch AM, See RE (1995). Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment. Psychopharmacology (Berl) 118: 338-346.
33. Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW (1998). Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18: 263-271. (Pubitemid 28085525)
34. Neumaier JF, Vincow ES, Arvanitogiannis A, Wise RA, Carlezon WA Jr (2002). Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. J Neurosci 22: 10856-10863. (Pubitemid 36005160)
35. Orio L, Edwards S, George O, Parsons LH, Koob GF (2009). A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J Neurosci 29: 4846-4857.
36. Parsons LH, Justice JB Jr (1993). Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J Neurochem 61: 1611-1619. (Pubitemid 23317180)
37. Paterson NE, Markou A (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. NeuroReport 14: 2229-2232.
38. Peraile I, Torres E, Mayado A, Izco M, Lopez-Jimenez A, Lopez-Moreno JA et al (2010). Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice. Br J Pharmacol 159: 201-211.
39. Reed SC, Haney M, Evans SM, Vadhan NP, Rubin E, Foltin RW (2009). Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend 102: 102-107.
40. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223. (Pubitemid 17131228)
41. Roberts DC, Corcoran ME, Fibiger HC (1977). On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6: 615-620. (Pubitemid 8147152)
42. Schmidt HD, Pierce RC (2010). Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci 1187: 35-75.
43. Steketee JD (2005). Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol 17: 69-86. (Pubitemid 44174001)
44. Stuber GD, Britt JP, Bonci A (2011). Optogenetic modulation of neural circuits that underlie reward seeking. Biol Psychiatry 71: 1061-1067.
45. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151: 99-120. (Pubitemid 30646415)
46. Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P et al (2006). Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26: 3206-3209.
47. Wheeler RA, Carelli RM (2009). Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 56(Suppl 1): 149-159.
48. Willuhn I, Wanat MJ, Clark JJ, Phillips PE (2010). Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci 3: 29-71.
49. Yorgason JT, España RA, Jones SR (2011). Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.
50. Zapata A, Chefer VI, Ator R, Shippenberg TS, Rocha BA (2003). Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice. Eur J Neurosci 17: 590-596. (Pubitemid 36255895)
51. Zimmer BA, Oleson EB, Roberts DCS (2012). The motivation to self-administer is increased after a history of spiking brain levels of cocaine. Neuropsychopharmacology 37: 1901-1910.